Search research articles
Contact Us
Filters
Showing results (111-120 of 346) with videos related to
Page
of 35
Sort By:
BMC Cancer
|
December 13, 2022
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial
Marie Lange, Bénédicte Clarisse, Alexandra Leconte, et al.
Bulletin Du Cancer
|
September 10, 2019
[Relapse surveillance of patients with testicular germ cell tumor]
Emeline Orillard, Elodie Klajer, Elsa Kalbacher, et al.
Plos One
|
November 13, 2025
Remotely supervised online cognitive training to reduce cognitive difficulties following chemotherapy in patients treated for localized breast cancer: Protocol of the Cog-Stim2 multicenter randomized controlled trial
Marie Bousquet, Marie Lange, Justine Lequesne, et al.
BMC Cancer
|
September 26, 2021
CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
Elodie Coquan, Pierre-Emmanuel Brachet, Idlir Licaj, et al.
European Urology
|
August 19, 2008
Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer
Antoine Italiano, Cécile Ortholan, Stéphane Oudard, et al.
BJU International
|
March 17, 2010
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study
Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, et al.
The Lancet. Oncology
|
December 24, 2023
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
Christian Pfister, Gwenaelle Gravis, Aude Flechon, et al.
La Revue Du Praticien
|
February 17, 2012
[Management of adverse effects of targeted therapy toxicities in oncology]
Elodie Coquan, Patrick Henri, Sixtine de Raucourt, et al.
Bulletin Du Cancer
|
January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer]
Renaud Sabatier, Christophe Hennequin, Jérôme Martin-Babau, et al.
Bulletin Du Cancer
|
June 23, 2022
[Metastatic renal cell carcinoma: Management of toxicities of combinations]
Florence Joly, Jean-Marie Michot, Louis Marie Dourthe, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 346) with videos related to
Sort By:
Page
of 35
BMC Cancer
|
December 13, 2022
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial
Marie Lange, Bénédicte Clarisse, Alexandra Leconte, et al.
Bulletin Du Cancer
|
September 10, 2019
[Relapse surveillance of patients with testicular germ cell tumor]
Emeline Orillard, Elodie Klajer, Elsa Kalbacher, et al.
Plos One
|
November 13, 2025
Remotely supervised online cognitive training to reduce cognitive difficulties following chemotherapy in patients treated for localized breast cancer: Protocol of the Cog-Stim2 multicenter randomized controlled trial
Marie Bousquet, Marie Lange, Justine Lequesne, et al.
BMC Cancer
|
September 26, 2021
CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
Elodie Coquan, Pierre-Emmanuel Brachet, Idlir Licaj, et al.
European Urology
|
August 19, 2008
Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer
Antoine Italiano, Cécile Ortholan, Stéphane Oudard, et al.
BJU International
|
March 17, 2010
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study
Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, et al.
The Lancet. Oncology
|
December 24, 2023
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
Christian Pfister, Gwenaelle Gravis, Aude Flechon, et al.
La Revue Du Praticien
|
February 17, 2012
[Management of adverse effects of targeted therapy toxicities in oncology]
Elodie Coquan, Patrick Henri, Sixtine de Raucourt, et al.
Bulletin Du Cancer
|
January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer]
Renaud Sabatier, Christophe Hennequin, Jérôme Martin-Babau, et al.
Bulletin Du Cancer
|
June 23, 2022
[Metastatic renal cell carcinoma: Management of toxicities of combinations]
Florence Joly, Jean-Marie Michot, Louis Marie Dourthe, et al.
Page
of 35